Skip to content
Compare prices

Maintenance

How to Keep Weight Off After Stopping Mounjaro

Stopping is the least discussed part of Mounjaro treatment, and the part the evidence is bluntest about: without a plan, most people regain. This guide covers what actually happens in your body when the injections stop, what the stopping trial really found, and the habits, timing and maintenance options that separate people who keep the result from people who watch it come back.

  • Written by Nick Johnson, Independent Prescription Pricing Analyst
  • Last reviewed 30 August 2026
  • Information, not medical advice

Key facts

  • In the SURMOUNT-4 trial, people who stopped tirzepatide after 36 weeks regained on average about 14% of their body weight over the following year, while those who continued lost a further 5.5%.
  • Even so, the group that stopped remained, on average, below their starting weight at the end of the trial. Regain is the default, not the destiny.
  • Appetite and food noise return gradually over the weeks after the last dose as the medicine leaves your system. Expect it, name it, and it loses half its power.
  • Stopping is a decision to plan with your prescriber, not something to let a reorder screen or an undisclosed BMI cut off decide for you.
  • Stopping entirely is not the only option: some prescribers support maintenance dosing at a lower strength or with spaced doses.

What happens in your body when the injections stop

Mounjaro works by acting on two gut hormone receptors, GLP-1 and GIP, quietening appetite and cravings. Tirzepatide’s half-life is about five days, so nothing changes overnight; over the following weeks the level falls away and the biology it was holding back returns. Hunger signals strengthen, food noise creeps back, and portions that felt impossible start to feel normal again.

Underneath that sits the harder problem: a body that has lost weight defends its old one. Research going back to the 1990s shows that after weight loss, people burn roughly 10 to 15% fewer calories than predicted for their new size, an adaptation that can persist for years. Our guide to why weight loss slows covers that biology. None of this means regain is a personal failure; it means the months after stopping are exactly when structure matters most.

What the stopping trial actually found

SURMOUNT-4 is the study built to answer this question. All participants took tirzepatide for 36 weeks, losing around a fifth of their body weight, then half switched to placebo without knowing. Over the next year, the placebo group regained on average about 14% of body weight while the continuing group lost a further 5.5%.

Two honest readings of that result. The discouraging one: the medicine was doing real, ongoing work, and removing it removed the work. The encouraging one: even the group that stopped remained on average below their starting weight at the end of the trial, and behind the averages, some people held nearly all of their loss. The habits people carried into the stopping period, not luck, are the best explanation for who ended up where.

Plan the stop, do not fall into it

The worst version of stopping is the accidental one: a surprise BMI cut off, a lapsed subscription, a supply gap. Appetite returns with no plan in place and the regain pattern starts immediately. If your BMI is approaching the healthy range, read the pharmacy BMI cut offs guide before your provider makes the decision for you.

A planned stop looks different:

  • Decide with your prescriber, including whether to step down through lower doses rather than stopping outright, and what the review points afterwards will be.
  • Use the last months as a runway. While appetite is still suppressed, lock in the eating pattern, protein habit and training routine that will have to do the job alone. Habits built under easy conditions are the ones that survive hard ones.
  • Consider maintenance dosing instead. Some pharmacies support long-term maintenance at a lower strength or with spaced doses; the maintenance friendly pharmacies directory lists who states what, and the maintenance price list covers costs.

The habits that carry the result

Protein and fibre at every meal. Protein preserves muscle and satisfies; soluble fibre from oats, beans, vegetables and seeds slows digestion and blunts hunger. These are the two levers that partially replace what the medicine was doing. The nutrition guide covers building meals this way.

Resistance training, non-negotiable. The NHS guideline of at least 150 minutes of moderate activity a week plus strength work twice a week is the maintenance floor, not a stretch goal. Muscle is what keeps your calorie burn up; it is also the first thing lost in unplanned regain-and-crash cycles.

Handle emotional eating before it handles you. Stress, boredom and low mood drove eating patterns long before the medicine arrived and they will be waiting after it. The emotional eating guide covers practical tools; sleep and stress management count as weight maintenance, not extras.

Keep goals boring and repeatable. A daily walk, meals cooked at home most days, a consistent weigh-in cadence. Consistency beats intensity everywhere in maintenance.

Review the rest of your health. Thyroid problems, diabetes, menopause and some common medicines all influence weight. If maintenance feels harder than it should, that is a GP conversation, not a willpower problem.

Watch the trend and act early

Pick a weigh-in rhythm you can keep, weekly at the same time of day works for most, and track waist, photos and how clothes fit alongside it; the free Augo app is built for exactly this. Then set a personal action line before you need it: an amount of regain, perhaps 3 to 5% of your body weight, at which you act rather than hope.

Acting early means an honest habits audit, a GP or pharmacy review, and if you and a prescriber agree, restarting treatment before the regain compounds. Restarting has its own rules, including going back through titration after a long break; the restarting guide covers them. And if it comes to that, restart from the best current price, not the first pharmacy you find. If you want company from people holding the same line, the free UK Monjour forum is full of them.

Common questions

Will I definitely regain weight after stopping Mounjaro?

No, but the odds lean that way without deliberate habits. The stopping trial found an average regain of about 14% of body weight over a year, yet the averages hide wide variation, and the group that stopped still ended the trial below their starting weight on average.

How quickly does appetite come back?

Gradually over several weeks. Tirzepatide’s half-life is about five days, so the medicine fades rather than switching off. Many people notice hunger and food noise strengthening from the second or third week after the last dose.

Should I taper off Mounjaro or just stop?

That is a prescriber decision. There is no mandated taper in the licence, but many prescribers prefer stepping down through lower doses so appetite returns in stages rather than all at once. Either way, the stop should be planned, with the final months used to build the habits that take over.

Can I stay on a low dose for maintenance instead of stopping?

Some prescribers support maintenance dosing at a lower strength or with spaced doses, and some do not; policies vary widely between pharmacies. If long-term maintenance is your plan, choose a maintenance friendly pharmacy deliberately and ask for its policy in writing.

What should I do if the weight starts coming back?

Act at a pre-agreed line rather than waiting. Audit eating, activity and sleep honestly, book a GP or pharmacy review, and discuss restarting treatment if appropriate. Restarting after a long break means going back through titration from the starting dose.

Do the health benefits disappear when I stop?

Benefits tied to the weight you keep off, and to the fitness and eating habits you hold, remain yours. Improvements that depended on the medicine’s ongoing effects, and on weight that returns, fade with regain, which is exactly why protecting the loss matters.

Sources

Monj is an independent price information service operated by Medstack Ltd. It does not sell, prescribe or supply medicines and does not give medical advice. Stopping, tapering, maintenance dosing and restarting are decisions for you and your prescriber. Report suspected side effects through the MHRA Yellow Card scheme.

Monj is an independent price comparison index operated by Medstack Ltd. We are not a pharmacy and we do not sell, prescribe, supply or dispense medicines. Listings are ranked strictly by the lowest total patient price, with alphabetical order used to break ties. No pharmacy can pay for placement, ranking or badges. Some outbound links earn a referral commission, and this never affects position or inclusion. Read the full independence statement.